Cargando…
Cardiotoxicity of Anticancer Therapeutics
As cancer therapeutics continues to improve and progress, the adverse side effects associated with anticancer treatments have also attracted more attention and have become extensively explored. Consequently, the importance of posttreatment follow-ups is becoming increasingly relevant to the discussi...
Autores principales: | Dong, Jerry, Chen, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810267/ https://www.ncbi.nlm.nih.gov/pubmed/29473044 http://dx.doi.org/10.3389/fcvm.2018.00009 |
Ejemplares similares
-
Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments
por: Audebrand, Anais, et al.
Publicado: (2020) -
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
por: Morelli, Marco Bruno, et al.
Publicado: (2022) -
Novel Therapeutics for Anthracycline Induced Cardiotoxicity
por: Vuong, Jacqueline T., et al.
Publicado: (2022) -
microRNA-377 Signaling Modulates Anticancer Drug-Induced Cardiotoxicity in Mice
por: Henderson, John, et al.
Publicado: (2021) -
Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity
por: Schwach, Verena, et al.
Publicado: (2020)